AmerisourceBergen Stock Forecast, Price & News

-0.76 (-0.61 %)
(As of 09/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume1.69 million shs
Average Volume1.04 million shs
Market Capitalization$25.66 billion
P/E RatioN/A
Dividend Yield1.42%
30 days | 90 days | 365 days | Advanced Chart
Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for AmerisourceBergen and its competitors with MarketBeat's FREE daily newsletter.

AmerisourceBergen logo

About AmerisourceBergen

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name; specialty brand-name and generic pharmaceuticals; over-the-counter healthcare products; home healthcare supplies and equipment; and related services to healthcare providers, including acute care hospitals and health systems; independent and chain retail pharmacies; mail order pharmacies; medical clinics; and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health; and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Conshohocken, PA.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

2.92 out of 5 stars

Medical Sector

11th out of 1,351 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 7 stocks

Analyst Opinion: 2.3Community Rank: 4.4Dividend Strength: 2.5Insider Behavior: 4.2Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

Is AmerisourceBergen a buy right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AmerisourceBergen stock.
View analyst ratings for AmerisourceBergen
or view top-rated stocks.

What stocks does MarketBeat like better than AmerisourceBergen?

Wall Street analysts have given AmerisourceBergen a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AmerisourceBergen wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting AmerisourceBergen?

AmerisourceBergen saw a decline in short interest in August. As of August 13th, there was short interest totaling 1,540,000 shares, a decline of 25.6% from the July 29th total of 2,070,000 shares. Based on an average trading volume of 886,300 shares, the short-interest ratio is presently 1.7 days. Currently, 1.0% of the shares of the company are sold short.
View AmerisourceBergen's Short Interest

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for AmerisourceBergen

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Co. (NYSE:ABC) posted its quarterly earnings data on Tuesday, August, 3rd. The company reported $2.16 EPS for the quarter, beating the Zacks' consensus estimate of $2.04 by $0.12. The company had revenue of $53.41 billion for the quarter, compared to analyst estimates of $52.62 billion. AmerisourceBergen had a negative net margin of 1.83% and a negative trailing twelve-month return on equity of 694.83%. The firm's quarterly revenue was up 17.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.85 EPS.
View AmerisourceBergen's earnings history

How has AmerisourceBergen's stock been impacted by COVID-19?

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ABC stock has increased by 45.3% and is now trading at $123.47.
View which stocks have been most impacted by COVID-19

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen announced a quarterly dividend on Wednesday, August 4th. Investors of record on Monday, August 16th will be given a dividend of $0.44 per share on Tuesday, September 7th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date is Friday, August 13th.
View AmerisourceBergen's dividend history

Is AmerisourceBergen a good dividend stock?

AmerisourceBergen pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.42%. The dividend payout ratio of AmerisourceBergen is 22.28%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 16.57% next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.
View AmerisourceBergen's dividend history.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen updated its FY 2021 earnings guidance on Wednesday, August, 25th. The company provided earnings per share (EPS) guidance of $9.150-$9.300 for the period, compared to the Thomson Reuters consensus estimate of $9.030. The company issued revenue guidance of -.

What price target have analysts set for ABC?

10 brokerages have issued twelve-month price targets for AmerisourceBergen's shares. Their forecasts range from $114.00 to $162.00. On average, they expect AmerisourceBergen's stock price to reach $137.00 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price.
View analysts' price targets for AmerisourceBergen
or view top-rated stocks among Wall Street analysts.

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the following people:
  • Steven H. Collis, Chairman, President & Chief Executive Officer (LinkedIn Profile)
  • James Francis Cleary, Chief Financial Officer & Executive Vice President
  • Kathy Habecker Gaddes, Chief Compliance Officer & Executive Officer
  • John G. Chou, Chief Legal Officer & Executive Vice President (LinkedIn Profile)
  • Gina K. Clark, Chief Communications & Administration Officer, EVP

What is Steve Collis' approval rating as AmerisourceBergen's CEO?

447 employees have rated AmerisourceBergen CEO Steve Collis on Glassdoor.com. Steve Collis has an approval rating of 83% among AmerisourceBergen's employees.

Who are some of AmerisourceBergen's key competitors?

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include NVIDIA (NVDA), Intel (INTC), AbbVie (ABBV), The Walt Disney (DIS), CVS Health (CVS), Johnson & Johnson (JNJ), AT&T (T), JPMorgan Chase & Co. (JPM), The Home Depot (HD) and Pfizer (PFE).

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.24%), BlackRock Inc. (5.55%), JPMorgan Chase & Co. (3.85%), State Street Corp (3.13%), Boston Partners (2.29%) and FMR LLC (1.78%). Company insiders that own AmerisourceBergen stock include Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, Jane E Md Henney, John G Chou, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Robert P Mauch, Silvana Battaglia and Steven H Collis.
View institutional ownership trends for AmerisourceBergen

Which institutional investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Royal Bank of Canada, BlackRock Inc., Lazard Asset Management LLC, AQR Capital Management LLC, Renaissance Technologies LLC, Bank of New York Mellon Corp, and Boston Partners. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Robert P Mauch, Silvana Battaglia, and Steven H Collis.
View insider buying and selling activity for AmerisourceBergen
or view top insider-selling stocks.

Which institutional investors are buying AmerisourceBergen stock?

ABC stock was acquired by a variety of institutional investors in the last quarter, including Amundi, JPMorgan Chase & Co., Schonfeld Strategic Advisors LLC, PNC Financial Services Group Inc., Neuberger Berman Group LLC, TimesSquare Capital Management LLC, APG Asset Management N.V., and Scout Investments Inc..
View insider buying and selling activity for AmerisourceBergen
or or view top insider-buying stocks.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $123.47.

How much money does AmerisourceBergen make?

AmerisourceBergen has a market capitalization of $25.66 billion and generates $189.89 billion in revenue each year. The company earns $-3,408,720,000.00 in net income (profit) each year or $7.90 on an earnings per share basis.

How many employees does AmerisourceBergen have?

AmerisourceBergen employs 22,000 workers across the globe.

Does AmerisourceBergen have any subsidiaries?

The following companies are subsidiares of AmerisourceBergen: ASD Specialty Healthcare LLC, Access M.D., Alliance Healthcare, Amerisource Receivables Financial Corporation, AmerisourceBergen Drug Corporation, AmerisourceBergen Global Holdings GmbH, AmerisourceBergen Global Manufacturer Services GmbH, AmerisourceBergen Group AG, AmerisourceBergen International Holdings Inc., AmerisourceBergen Luxembourg S.a.r.L., AmerisourceBergen Services Corporation, AmerisourceBergen Specialty Group LLC, Anderson Packaging, AutoMed Technologies, BPL Group LLC, BPLH Ireland Unlimited Company, Bellco Health, Brecon Pharmaceuticals, Bridge Medical Inc, CD Smith Healthcare, H. D. Smith, IgG America, International Oncology Network Solutions Inc., IntrinsiQ, Lash Group, MWI Veterinary Supply, MWI Veterinary Supply Co., MWI Veterinary Supply Inc., Network for Medical Communications & Research, PharMEDium Healthcare, Pharmacy Healthcare Solutions, Premier Source, St. Francis Group, Trent Drug, US Bioservices, World Courier, World Courier Group S.à r.l., and Xcenda.

When was AmerisourceBergen founded?

AmerisourceBergen was founded in 2001.

What is AmerisourceBergen's official website?

The official website for AmerisourceBergen is www.amerisourcebergen.com.

Where are AmerisourceBergen's headquarters?

AmerisourceBergen is headquartered at 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at (610) 727-7000 or via email at [email protected]

This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.